These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32064194)

  • 1. Frequency of Intraoperative Hypotension After the Induction of Anesthesia in Hypertensive Patients with Preoperative Angiotensin-converting Enzyme Inhibitors.
    Salim F; Khan F; Nasir M; Ali R; Iqbal A; Raza A
    Cureus; 2020 Jan; 12(1):e6614. PubMed ID: 32064194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries.
    Yoon U; Setren A; Chen A; Nguyen T; Torjman M; Kennedy T
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):508-513. PubMed ID: 32029371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of angiotensin-converting enzyme inhibitors on hypotension after anesthetic induction: is the preoperative discontinuation of this drug necessary?
    da Costa VV; Caldas AC; Nunes LG; Beraldo PS; Saraiva RA
    Rev Bras Anestesiol; 2009; 59(6):704-15. PubMed ID: 20011860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.
    Hollmann C; Fernandes NL; Biccard BM
    Anesth Analg; 2018 Sep; 127(3):678-687. PubMed ID: 29381513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin system inhibitors in a general surgical population.
    Comfere T; Sprung J; Kumar MM; Draper M; Wilson DP; Williams BA; Danielson DR; Liedl L; Warner DO
    Anesth Analg; 2005 Mar; 100(3):636-644. PubMed ID: 15728043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
    Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Vasopressin and Analogues to Treat Intraoperative Refractory Hypotension in Patients Prescribed Angiotensin-Converting Enzyme Inhibitors Undergoing General Anesthesia: A Systematic Review.
    Hedman KF; Mann CL; Spulecki C; Castner J
    AANA J; 2016 Dec; 84(6):413-419. PubMed ID: 28235174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of hypotension during anesthesia induction in patients with hypertension on medication: a retrospective observational study.
    Hojo T; Kimura Y; Shibuya M; Fujisawa T
    BMC Anesthesiol; 2022 Nov; 22(1):343. PubMed ID: 36368916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Renin-Angiotensin System (RAS) Blockade May Not Induce Hypotension During Anaesthesia for Bariatric Surgery.
    Salvetti G; Di Salvo C; Ceccarini G; Abramo A; Fierabracci P; Magno S; Piaggi P; Vitti P; Santini F
    Obes Surg; 2016 Jun; 26(6):1303-7. PubMed ID: 26328531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the angiotensin II antagonists be discontinued before surgery?
    Bertrand M; Godet G; Meersschaert K; Brun L; Salcedo E; Coriat P
    Anesth Analg; 2001 Jan; 92(1):26-30. PubMed ID: 11133595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis.
    Ling Q; Gu Y; Chen J; Chen Y; Shi Y; Zhao G; Zhu Q
    BMC Anesthesiol; 2018 Feb; 18(1):26. PubMed ID: 29482507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients.
    Twersky RS; Goel V; Narayan P; Weedon J
    Anesth Analg; 2014 May; 118(5):938-44. PubMed ID: 24681657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis.
    Brugts JJ; van Vark L; Akkerhuis M; Bertrand M; Fox K; Mourad JJ; Boersma E
    Int J Cardiol; 2015 Feb; 181():425-9. PubMed ID: 25569271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.
    Katragadda S; Arora RR
    Am J Ther; 2010; 17(1):e11-23. PubMed ID: 20090429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
    Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.